For information about COVID-19, including symptoms and prevention, please read our COVID-19 patient guide. Please also consider supporting Weill Cornell Medicine’s efforts against the pandemic.

Using influenza surveillance networks to estimate state-specific prevalence of SARS-CoV-2 in the United States

In a new article published in Science Translational Medicine, Dr. Nathaniel Hupert, associate professor of population health sciences and medicine at Weill Cornell Medicine, worked with colleagues to show how influenza-like illness (ILI) outpatient surveillance data can be used to estimate the prevalence of SARS-CoV-2 in the United States. To date, detection of the COVID-19 virus has relied heavily on reverse transcription polymerase chain reaction (PT-PCR) testing, which has limited availability and high false-negative rates. Dr. Nathaniel and his fellow researchers found a surge of non-influenza ILI above the seasonal average in March 2020, which helped them build a conceptual model for the COVID-19 pandemic characterized by a rapid spread across the country. With over 80% of infected patients remaining undetected, the researchers stress the importance of using seroprevalence data and syndromic surveillance for early detection and understanding of emerging infectious diseases.

Population Health Sciences 402 E. 67th St. New York, NY 10065 Phone: (646) 962-8078